...

首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Pitavastatin and prednisolone, novel drug combination, display significant synergy in ovarian cancer cell lines

【24h】

Pitavastatin and prednisolone, novel drug combination, display significant synergy in ovarian cancer cell lines

机译：匹伐他汀和泼尼松龙这两种新药组合在卵巢癌细胞系中显示出明显的协同作用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2016年第null期|共1页
作者
Abdullah M. I.; Khanim F.; Richarson A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Pitavastatin and prednisolone, novel drug combination, display significant synergy in ovarian cancer cell lines [J] . Abdullah M. I., Khanim F., Richarson A. European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：匹伐他汀和泼尼松龙这两种新药组合在卵巢癌细胞系中显示出明显的协同作用
2. Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death [J] . Marwan Ibrahim Abdullah, Mohammed Najim Abed, Farhat Khanim, Scientific reports. . 2019,第1期

机译：筛选批准的药物图书馆揭示了泼尼松龙促进与匹马汀菌素诱导卵巢癌细胞死亡的促进
3. Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines. [J] . Viale M, Pastrone I, Pellecchia C, Anti-cancer drugs . 1998,第5期

机译：顺铂-普鲁卡因复合物DPR与抗癌药的组合可增加针对卵巢癌细胞系的细胞毒性。
4. Proteomic comparison of ascites from ovarian cancer patients and ovarian cancer cell lines using HPLC-orbitrap mass spectrometry [C] . Guangyu Zhang, Rodney Rocconi, Michael Finan, ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：卵巢癌患者腹水和卵巢癌细胞系的蛋白质组学比较使用HPLC-横谱法质谱法
5. Liposomal Combination Drug and siRNA Delivery to Combat Drug-Resistant Ovarian Cancer [D] . Miller, Emily Margaret 2018

机译：脂质体组合药物和siRNA递送，用于打击耐药卵巢癌
6. Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death [O] . Marwan Ibrahim Abdullah, Mohammed Najim Abed, Farhat Khanim, -1

机译：筛选批准的药物库显示泼尼松龙与匹伐他汀协同作用可诱导卵巢癌细胞死亡
7. Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death [O] . Marwan Ibrahim Abdullah, Mohammed Najim Abed, Farhat Khanim, 2019

机译：筛选批准的药物图书馆揭示了泼尼松龙促进与匹马汀菌素诱导卵巢癌细胞死亡的促进

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号